TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ACS DOBFAR SPA

Infectious DiseaseDermatologyGastroenterology
Generics

ACS DOBFAR SPA is a generic drug manufacturer focused on Infectious Disease, Dermatology, Gastroenterology. Key products include MEROPENEM.

1997
Since
6
Drugs
-
Trials
37
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

MEROPENEM 2026-02-17
Labeling
MEROPENEM 2025-12-11
Labeling
MEROPENEM 2025-10-01
Labeling
MEROPENEM 2025-10-01
Labeling
MEROPENEM 2025-09-17
Labeling
MEROPENEM 2025-09-17
Labeling
MEROPENEM 2025-09-17
Labeling
MEROPENEM 2025-08-21
Labeling
MEROPENEM 2025-08-21
Labeling
MEROPENEM 2025-08-21
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
2 drugs
Dermatology 25%
1 drugs
Gastroenterology 25%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Dermatology
CASPER PHARMA LLC big-pharma
Infectious Disease, Gastroenterology, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology